New way to predict cognitive decline could benefit clinical trials
A new test could help to more accurately predict and measure the rate of cognitive decline among those with mild dementia, leading to more effective clinical trials, according to a new report.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.